Skip to Main Content

It was not your typical CRISPR experiment. The scientists had just injected a mouse’s tail with magnetic nanoparticles bound to an exotic virus containing today’s genome editor of choice. They then plopped the mouse belly-side down atop a block magnet about the size of a deck of cards, positioning it just so. Even with all their attention to detail, however, “we were never sure it would work,” admits bioengineer Gang Bao of Rice University. “We figured, let’s just see what happens.”

What happened was that the magnetic field quickly steered the CRISPR-containing magnetic nanoparticles to the surface of the mouse’s liver cells and kept the particles well away from the heart, lungs, brain, and other organs. The liver is a big target, which makes hitting it the biological version of hitting the proverbial barn door, but the ability to direct CRISPR to a target organ and only a target organ was a big step toward solving one of the toughest challenges for genome editing: precise delivery.

advertisement

CRISPR is easy enough to design and produce that thousands of scientists are using it to identify the function of specific genes, create animal models of genetic disorders, and pursue CRISPR-based therapies for diseases as different as Duchenne muscular dystrophy and a form of congenital blindness. But the “easy” part stops at cells’ outer boundaries. Getting CRISPR to the right cells, bypassing all others, and slipping it through their membranes is the opposite of easy.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect

To submit a correction request, please visit our Contact Us page.